1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Nexgenix Pharmaceuticals, LLC - Product Pipeline Review - 2013

Nexgenix Pharmaceuticals, LLC - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 23 pages

Nexgenix Pharmaceuticals, LLC - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Nexgenix Pharmaceuticals, LLC - Product Pipeline Review - 2013” provides data on the Nexgenix Pharmaceuticals, LLC’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Nexgenix Pharmaceuticals, LLC’s corporate website, SEC filings, investor presentations and featured press releases, both from Nexgenix Pharmaceuticals, LLC and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Nexgenix Pharmaceuticals, LLC - Brief Nexgenix Pharmaceuticals, LLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Nexgenix Pharmaceuticals, LLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Nexgenix Pharmaceuticals, LLC with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Nexgenix Pharmaceuticals, LLC’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Nexgenix Pharmaceuticals, LLC’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Nexgenix Pharmaceuticals, LLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Nexgenix Pharmaceuticals, LLC’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Nexgenix Pharmaceuticals, LLC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Nexgenix Pharmaceuticals, LLC and identify potential opportunities in those areas.

Table Of Contents

Nexgenix Pharmaceuticals, LLC - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Nexgenix Pharmaceuticals, LLC Snapshot 4
Nexgenix Pharmaceuticals, LLC Overview 4
Key Information 4
Key Facts 4
Nexgenix Pharmaceuticals, LLC - Research and Development Overview 5
Key Therapeutic Areas 5
Nexgenix Pharmaceuticals, LLC - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Nexgenix Pharmaceuticals, LLC - Pipeline Products Glance 9
Nexgenix Pharmaceuticals, LLC - Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Nexgenix Pharmaceuticals, LLC - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Nexgenix Pharmaceuticals, LLC - Drug Profiles 11
NX-101 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
NXD-30001 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
Pak Inhibitors 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Nexgenix Pharmaceuticals, LLC - Pipeline Analysis 15
Nexgenix Pharmaceuticals, LLC - Pipeline Products by Therapeutic Class 15
Nexgenix Pharmaceuticals, LLC - Pipeline Products by Target 16
Nexgenix Pharmaceuticals, LLC - Pipeline Products by Route of Administration 17
Nexgenix Pharmaceuticals, LLC - Pipeline Products by Molecule Type 18
Nexgenix Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action 19
Nexgenix Pharmaceuticals, LLC - Recent Pipeline Updates 20
Nexgenix Pharmaceuticals, LLC - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23



List of Tables

Nexgenix Pharmaceuticals, LLC, Key Information 4
Nexgenix Pharmaceuticals, LLC, Key Facts 4
Nexgenix Pharmaceuticals, LLC - Pipeline by Indication, 2013 6
Nexgenix Pharmaceuticals, LLC - Pipeline by Stage of Development, 2013 7
Nexgenix Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2013 8
Nexgenix Pharmaceuticals, LLC - Phase I, 2013 9
Nexgenix Pharmaceuticals, LLC - Preclinical, 2013 10
Nexgenix Pharmaceuticals, LLC - Pipeline by Therapeutic Class, 2013 15
Nexgenix Pharmaceuticals, LLC - Pipeline by Target, 2013 16
Nexgenix Pharmaceuticals, LLC - Pipeline by Route of Administration, 2013 17
Nexgenix Pharmaceuticals, LLC - Pipeline by Molecule Type, 2013 18
Nexgenix Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action, 2013 19
Nexgenix Pharmaceuticals, LLC - Recent Pipeline Updates, 2013 20



List of Figures

Nexgenix Pharmaceuticals, LLC - Pipeline by Top 10 Indication, 2013 6
Nexgenix Pharmaceuticals, LLC - Pipeline by Stage of Development, 2013 7
Nexgenix Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2013 8
Nexgenix Pharmaceuticals, LLC - Pipeline by Top 10 Therapeutic Class, 2013 15
Nexgenix Pharmaceuticals, LLC - Pipeline by Top 10 Target, 2013 16
Nexgenix Pharmaceuticals, LLC - Pipeline by Top 10 Route of Administration, 2013 17
Nexgenix Pharmaceuticals, LLC - Pipeline Products by Top 10 Mechanism of Action, 2013 19



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
cAMP and cAMP Inhibited cGMP 3%,5% Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016

cAMP and cAMP Inhibited cGMP 3%,5% Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2016 Summary Global Markets ...

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Iduronate 2 Sulfatase (Alpha L Iduronate ...

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016 Summary Global Markets ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.